<DOC>
	<DOCNO>NCT02766205</DOCNO>
	<brief_summary>The aim propose study identify predictor covert atrial fibrillation ( AF ) Embolic Stroke Undetermined Source ( ESUS ) patient develop prognostic score identification covert AF population .</brief_summary>
	<brief_title>Prediction AF ESUS</brief_title>
	<detailed_description>A new clinical entity term Embolic Stroke Undetermined Source ( ESUS ) recently introduce Cryptogenic Stroke/ESUS International Working Group , describe stroke patient source embolism remain undetected despite thorough investigation ; potential embolic source include diseases mitral aortic valve , leave cardiac chamber , proximal cerebral artery aortic arch venous system via paradoxical embolism . ESUS propose potential therapeutic entity possible indication anticoagulation , hypothesis currently test two randomize control trial . ESUS define visualized non-lacunar brain infarct absence ) extracranial intracranial atherosclerosis cause ≥50 % luminal stenosis artery supply area ischaemia , b ) major-risk cardioembolic source , c ) specific cause stroke ( e.g . arteritis , dissection , migraine/vasospasm , drug misuse ) . Major risk source cardioembolism include permanent paroxysmal atrial fibrillation , sustain atrial flutter , intracardiac thrombus , prosthetic cardiac valve , atrial myxoma cardiac tumour , mitral stenosis , recent ( &lt; 4 week ) myocardial infarction , leave ventricular ejection fraction le 30 % , valvular vegetation , infective endocarditis . Recently , group present descriptive analysis ESUS population derive Athens Stroke Registry . Among overall ischemic stroke population , 10 % patient classified ESUS . These stroke mild-moderate severity covert AF identify underlying etiopathogenetic mechanism approximately 40 % ESUS patient . The mortality risk ESUS patient low compare patient cardioembolic stroke despite similar rate stroke recurrence . Also , risk stroke recurrence high ESUS patient patient non-cardioembolic stroke could sign current antithrombotic strategy treat ESUS patient antiplatelets suboptimal . Indeed , currently , clear whether antiplatelets anticoagulant ideal antithrombotic strategy ESUS . Recently , two international , phase III , double-blind , randomize , control clinical trial launch aim investigate whether anticoagulant treatment superior antiplatelet treatment secondary prevention ESUS patient : Randomized Evaluation Secondary stroke Prevention Comparing Thrombin inhibitor dabigatran etexilate versus aspirin Embolic Stroke Undetermined Source ( RE-SPECT ESUS ) trial NAVIGATE trial compare dabigatran etexilate rivaroxaban respectively aspirin ESUS patient . It would clinically useful identify predictor covert AF ESUS population could possibly influence choice antithrombotic treatment , e.g . anticoagulant ESUS patient high risk covert AF , antiplatelets ESUS patient low risk covert AF .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Embolic stroke undetermined source ( ESUS ) define : Ischemic stroke ( include transient ischemic attack positive neuroimaging ) visualize brain CT MRI lacunar ( i.e. , subcortical infarct ≤1.5 cm ) , Absence cervical carotid atherosclerotic stenosis ( vertebral basilar artery stenosis case posterior circulation stroke ) , ≥ 50 % , occlusion artery supply area ischemia CT magnetic resonance ( MR ) angiography ultrasound , No history AF , document AF 12lead electrocardiogram ( ECG ) episode AF last 6 minute longer detect ≥ 24hour cardiac rhythm monitoring ( Holter telemetry ) , No intracardiac thrombus transthoracic echocardiography , No specific cause stroke identify routine clinical care ( e.g. , arteritis , dissection , migraine/vasospasm , drug abuse ) 2 . Age ≥18 year 3 . Written inform consent 1 . ≥ 50 % luminal stenosis occlusion artery supply area ischemia 2 . History AF 3 . Life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Embolic Stroke Undetermined Source</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>prognostic score</keyword>
</DOC>